KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to $2.9 billion.

  • Gsk's Other Non-Current Assets rose 1410.46% to $2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year increase of 1410.46%. This contributed to the annual value of $2.5 billion for FY2024, which is 2599.69% up from last year.
  • As of Q3 2025, Gsk's Other Non-Current Assets stood at $2.9 billion, which was up 1410.46% from $2.7 billion recorded in Q2 2025.
  • Over the past 5 years, Gsk's Other Non-Current Assets peaked at $2.9 billion during Q3 2025, and registered a low of $32.2 million during Q1 2022.
  • In the last 5 years, Gsk's Other Non-Current Assets had a median value of $2.0 billion in 2023 and averaged $1.9 billion.
  • As far as peak fluctuations go, Gsk's Other Non-Current Assets plummeted by 9763.86% in 2022, and later skyrocketed by 554650.11% in 2023.
  • Gsk's Other Non-Current Assets (Quarter) stood at $2.3 billion in 2021, then plummeted by 38.01% to $1.4 billion in 2022, then soared by 40.38% to $2.0 billion in 2023, then rose by 26.78% to $2.5 billion in 2024, then grew by 15.39% to $2.9 billion in 2025.
  • Its Other Non-Current Assets was $2.9 billion in Q3 2025, compared to $2.7 billion in Q2 2025 and $2.5 billion in Q1 2025.